Rockefeller Capital Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Rockefeller Capital Management’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,114	Closed	-$15K	–	4300
2022 Q3	$15K	Hold	1,114	–	–	﹤0.01%	2914
2022 Q2	$44K	Hold	1,114	–	–	﹤0.01%	2352
2022 Q1	$117K	Hold	1,114	–	–	﹤0.01%	1920
2021 Q4	$128K	Hold	1,114	–	–	﹤0.01%	1830
2021 Q3	$421K	Buy	+1,114	New	+$374K	﹤0.01%	1324

Other funds holding NEXI

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Rockefeller Capital Management's NEXI Position: Q4 2022 in Review

Rockefeller Capital Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2022, closing a stake of 1,114 shares — an estimated $15K sold.

Rockefeller Capital Management first reported a position in NEXI in Q3 2021 and held it in 5 quarters. The position peaked at $421K in Q3 2021. 29 funds tracked by Wall St. Rank hold NEXI as of Q4 2022.

Rockefeller Capital Management reported no remaining NexImmune, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Rockefeller Capital Management sold 1,114 NexImmune, Inc. Common Stock shares in Q4 2022, an estimated $15K.
Rockefeller Capital Management first reported a position in NexImmune, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Rockefeller Capital Management's NexImmune, Inc. Common Stock position peaked at $421K in Q3 2021.
29 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2022.

Based on Rockefeller Capital Management's 13F filing for Q4 2022, filed 6 Mar 2023.